Search - tctmd.com

Displaying 21 - 40 of 305

Sort: Relevancy | Date

Presentation TCT 2024

TCT 890: Transcatheter Aortic Valve Replacement in Low-Risk Patients at Four or More Years: A Meta-Analysis of Randomized Trials

Presenter: John Connolly

October 28, 2024

Presentation TCT 2024

Mechanical Circulatory Support of High-Risk PCI With a Novel, Low-Profile pMCS: First Results of the Impella ECP Pivotal Study

Presenter: Amir Kaki

October 27, 2024

Presentation TCT 2024

TCT 141: Transcatheter Aortic-Valve Replacement (TAVR) Versus Surgical Aortic-Valve Replacement (SAVR) in Low-Risk Patients at Long Term Follow Up: Meta-Analysis of Randomized Controlled Trials

Presenter: Sunny Goel

October 27, 2024

Presentation TCT 2024

TCT 762: Long-Term Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Low and Intermediate Risk Patients: A Meta-Analysis of Randomized Controlled Trials

Presenter: Abdul Mueez Alam Kayani

October 27, 2024

Presentation TCT 2024

TCT 761: Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Systematic Review and Meta-Analysis

Presenter: Prakash Upreti

October 27, 2024

Presentation TCT 2024

TCT 146: Impact of Prosthesis-Patient Mismatch in Young and Low-Risk Patients After Newer Generation Balloon-Expandable Transcatheter Aortic Valve Replacement

Presenter: Kazuki Suruga

October 27, 2024

Presentation NY Valves 2024

Management of Aortic Stenosis in Low-Risk Patients – Current Options and Controversies

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

Health Related Quality of Life and Functional Status Outcomes Comparing Transcatheter and Surgical Aortic Valve Replacement in Low-Intermediate Risk Patients for Surgery: A Metanalysis of Randomized Control Trials

Presenter: Errol Christopher Moras

June 06, 2024

Presentation NY Valves 2024

Predictors of Mortality Following Transcatheter Aortic Valve Replacement in Patients With Classical Low-Flow Low-Gradient Severe Aortic Stenosis

Presenter: Besir Besir

June 06, 2024

Presentation NY Valves 2024

The Costs of Low-Risk TAVR Implant and All-Cause, Long-Term Follow Up Care in the Medicare Fee-For-Service Population

Presenter: Kael Wherry

June 06, 2024

Presentation NY Valves 2024

Outcomes of Patients With Low-Flow Low-Gradient and Normal-Flow Low-Gradient Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

Presenter: Besir Besir

June 06, 2024

Presentation NY Valves 2024

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Presenter: Ole De Backer

June 05, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation ACC 2024

Randomized, Double-blind, Placebo-controlled, Phase 3, Study To Evaluate Lerodalcibep Long-term Efficacy And Safety In Patients With, Or At Very-high Or High Risk, For Cardiovascular Disease On Stable Lipid-lowering Therapy

Presenter: Eric Quinton Klug

April 07, 2024

Presentation

A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery

February 28, 2024

Presentation AHA 2023

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Presenter: Jing Li

November 16, 2023

Presentation TCT 2023

TCT 444: Mid to Long-Term Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Muhammad Adil Afzal

October 26, 2023

Presentation TCT 2023

TCT 218: Transcatheter Aortic Valve Replacement Versus Conservative Management in Patients with Low-flow Very Low-gradient Aortic Stenosis

Presenter: Lakshay Chopra

October 26, 2023

Presentation TCT 2023

TCT 121: Change in Pulmonary Artery Systolic Pressure after Transcatheter Aortic Valve Replacement in Patients with Low-flow Low-gradient Aortic Stenosis and its Prognostic Implications

Presenter: Lakshay Chopra

October 26, 2023

Presentation TCT 2023

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Presenter: Rebecca Hahn

October 24, 2023

Advertisement

TCT 890: Transcatheter Aortic Valve Replacement in Low-Risk Patients at Four or More Years: A Meta-Analysis of Randomized Trials

Mechanical Circulatory Support of High-Risk PCI With a Novel, Low-Profile pMCS: First Results of the Impella ECP Pivotal Study

TCT 141: Transcatheter Aortic-Valve Replacement (TAVR) Versus Surgical Aortic-Valve Replacement (SAVR) in Low-Risk Patients at Long Term Follow Up: Meta-Analysis of Randomized Controlled Trials

TCT 762: Long-Term Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Low and Intermediate Risk Patients: A Meta-Analysis of Randomized Controlled Trials

TCT 761: Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Systematic Review and Meta-Analysis

TCT 146: Impact of Prosthesis-Patient Mismatch in Young and Low-Risk Patients After Newer Generation Balloon-Expandable Transcatheter Aortic Valve Replacement

Management of Aortic Stenosis in Low-Risk Patients – Current Options and Controversies

Health Related Quality of Life and Functional Status Outcomes Comparing Transcatheter and Surgical Aortic Valve Replacement in Low-Intermediate Risk Patients for Surgery: A Metanalysis of Randomized Control Trials

Predictors of Mortality Following Transcatheter Aortic Valve Replacement in Patients With Classical Low-Flow Low-Gradient Severe Aortic Stenosis

The Costs of Low-Risk TAVR Implant and All-Cause, Long-Term Follow Up Care in the Medicare Fee-For-Service Population

Outcomes of Patients With Low-Flow Low-Gradient and Normal-Flow Low-Gradient Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Randomized, Double-blind, Placebo-controlled, Phase 3, Study To Evaluate Lerodalcibep Long-term Efficacy And Safety In Patients With, Or At Very-high Or High Risk, For Cardiovascular Disease On Stable Lipid-lowering Therapy

A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

TCT 444: Mid to Long-Term Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

TCT 218: Transcatheter Aortic Valve Replacement Versus Conservative Management in Patients with Low-flow Very Low-gradient Aortic Stenosis

TCT 121: Change in Pulmonary Artery Systolic Pressure after Transcatheter Aortic Valve Replacement in Patients with Low-flow Low-gradient Aortic Stenosis and its Prognostic Implications

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content